日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of bofanglutide, a GLP-1 receptor agonist, in Chinese adults with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial

一项随机、双盲、安慰剂对照的2b期临床试验,旨在评估GLP-1受体激动剂波方鲁肽在中国超重或肥胖成年人中的疗效和安全性。

Ji, Linong; Gao, Leili; Tian, Junhang; Dong, Ruihua; Zhang, Zhongtao; Shu, Hongyan; Zhao, Jing; Zhao, Liyuan; He, Anshun; Xie, Tian; Li, Yue; Chen, Wei

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

口服索马鲁肽对高危 2 型糖尿病患者心血管危险因素的影响:SOUL 随机临床试验的事后二次分析

Mulvagh, Sharon L; Inzucchi, Silvio E; Marx, Nikolaus; Poulter, Neil R; Deanfield, John E; Pop-Busui, Rodica; Emerson, Scott S; Mann, Johannes F E; Engelmann, Mads D M; Hovingh, G Kees; Mandavya, Kabirdev; Davicevic-Elez, Zaklina; Jeppesen, Ole Kleist; Lorenzatti, Alberto; Oguz, Aytekin; Mankovsky, Boris; Deerochanawong, Chaicharn; Gorgojo-Martinez, Juan J; Ji, Linong; Bain, Stephen C; McGuire, Darren K; Buse, John B

From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce

从全球心肾代谢疾病管理指南到国家实施:指南研讨会工作组的视角

Wanner, Christoph; Cosentino, Francesco; Barnard-Kelly, Katharine; Battelino, Tadej; Blüher, Matthias; Boll, Helena N; Brosius, Frank C; Busetto, Luca; Ceriello, Antonio; Gavin, James R 3rd; Giorgino, Francesco; Green, Jennifer; Ji, Linong; Kellerer, Monika; Koob, Sue; Lalic, Nebojsa; Marx, Nikolaus; Nedungadi, Prashant; Parkin, Christopher G; Rodbard, Helena W; Rydén, Lars; Saboo, Banshi; Sheu, Wayne Huey-Herng; Standl, Eberhard; Tacke, Frank; Topsever, Pinar; Schnell, Oliver

Correction: Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications

更正:抗肥胖药物治疗停药后体重的变化轨迹

Wu, Han; Yang, Wenjia; Guo, Tong; Cai, Xiaoling; Ji, Linong

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

解决1型糖尿病合并慢性肾脏病治疗中未满足的需求:一项综述

Tuttle, Katherine R; Ji, Linong; Mathieu, Chantal; Rosen, Jonathan

CGM-derived efficacy and overall safety of once-weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetes

在2型糖尿病成人患者中,每周一次注射胰岛素efsitora alfa(efsitora)的CGM衍生疗效和总体安全性与给药当日相比

Martens, Thomas; Battelino, Tadej; Heller, Simon; Bhargava, Anuj; Ji, Linong; Murthy, Sreenivasa; Threlkeld, Rebecca J; Li, Xiaoqi; Murro, Ada Leticia; Syring, Kristen; Patel, Vidhi

Redefining evidence for teprotumumab in thyroid eye disease: an updated meta-analysis of efficacy and safety

重新定义替普鲁单抗治疗甲状腺眼病的证据:一项更新的疗效和安全性荟萃分析

Song, Rongjing; Zhao, Wei; Li, Shasha; Niu, Xiaofang; Guo, Jing; Zhang, Xiuying; Zhang, Xiaohong; Ji, Linong

External validation and application of a machine learning-based model for diabetes progression in prediabetes

外部验证和基于机器学习的糖尿病前期进展模型在糖尿病进展预测中的应用

Wang, Song; Huang, Qi; Luo, Yuxuan; Luo, Yingying; Wu, Honghan; Lian, Zhouhui; Ji, Linong; Zou, Xiantong

The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials

胰高血糖素样肽-1受体激动剂与报告的肌肉骨骼不良事件之间的关联:随机对照试验的系统评价和荟萃分析

Cao, Meng; Lin, Chu; Cai, Xiaoling; Lv, Fang; Yang, Wenjia; Ji, Linong

Taurine Alleviates Sepsis-Induced Myocardial Injury by Inhibiting NF-κB Pathway-Mediated Inflammation, Mitochondrial Dysfunction, and Apoptosis

牛磺酸通过抑制NF-κB通路介导的炎症、线粒体功能障碍和细胞凋亡来减轻脓毒症引起的心肌损伤

Feng, Junkai; Ma, Ting; Yang, Liu; Li, Min; Xiao, Dahai; Gong, Pengxin; Zhao, Ani; Li, Pu; Yao, Linong